Fondaparinux versus argatroban for the management of suspected or confirmed heparin-induced thrombocytopenia: a propensity score-matched cohort study.

Front Med (Lausanne) · 2026 · PMC13194571 · PMID 42180757

Europe PMC DOI

hedged sentence

0.1200

closest p · 2.4× alpha

0.1200

boldest claim

The sentences

did not reach statistical significancep = 0.12not close (p > 0.1)

In-hospital mortality was also higher in the argatroban group; however, this did not reach statistical significance in crude analysis (38.3% vs. 23.4%; p = 0.12) or regression analysis (aOR: 2.04; 95% CI: 0.80–5.15; p = 0.13).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.